These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration. Kim SW; Woo JE; Yoon YS; Lee S; Woo JM; Min JK Curr Pharm Des; 2019; 25(2):184-189. PubMed ID: 30892159 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration. Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy. Jo YJ; Kim WJ; Shin IH; Kim JY Korean J Ophthalmol; 2016 Apr; 30(2):114-20. PubMed ID: 27051259 [TBL] [Abstract][Full Text] [Related]
15. Anatomical effects of intravitreal anti-vascular endothelial growth factor injections on inner layers of the lesion-free retina. Demir N; Sevincli S; Kayhan B; Sonmez M Cutan Ocul Toxicol; 2021 Jun; 40(2):135-139. PubMed ID: 33944638 [TBL] [Abstract][Full Text] [Related]
16. The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration. Parlak M; Oner FH; Saatci AO Int Ophthalmol; 2015 Aug; 35(4):473-80. PubMed ID: 25059401 [TBL] [Abstract][Full Text] [Related]
17. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration. Park DH; Sun HJ; Lee SJ Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933 [TBL] [Abstract][Full Text] [Related]